ANCON Medical featured in national press
BBC Breakfast Paper Review on Sunday and national press outlets have highlighted ANCON Medical as a company to watch.
National press outlets including The Sunday Express, Daily Mail and Metro, have this week featured ANCON Medical in their innovative technology news. Reporting on upcoming trials on lung cancer biomarker detection through breath testing, the company reports that with successful progression, the technology could be available for use by medical professionals within 2 years.
Providing far more accurate readings than other models, the technology works at the level of nanoparticles and combines artificial intelligence to identify specific chemicals, or “biomarkers“, produced by a range of diseases. Previous devices have only been able to detect biomarkers when present in large quantities, and although initial trials involve lung cancer molecules, the technology will be able to detect a range of cancers and other diseases such as TB and dementia.